Evidence map›Paper›PMID 30009837›Full record

ArticleNeuropharmacology2018

A-type K

Ágota A Biró, Antoine Brémaud, Joanne Falck, Arnaud J Ruiz

Open access · hybridAbstract read
In one paragraph

Article in Neuropharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Reduced expression of the psychiatric risk gene DLG2 (PSD93) impairs hippocampal synaptic integration and plasticity.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Ágota A BiróUCL School of Pharmacy, Brunswick Square, London WC1N 1AX, United Kingdom.
Antoine BrémaudUCL School of Pharmacy, Brunswick Square, London WC1N 1AX, United Kingdom.
Joanne FalckUCL School of Pharmacy, Brunswick Square, London WC1N 1AX, United Kingdom.
Arnaud J RuizUCL School of Pharmacy, Brunswick Square, London WC1N 1AX, United Kingdom. Electronic address: a.ruiz@ucl.ac.uk.
University College London · GBMedway School of Pharmacy · GB

Funding

Medical Research Council G1000629
6 · The paper itself

Abstract

A-type K

Indexed as

4-AminopyridineAction PotentialsAnimalsDendritesDendritic SpinesExcitatory Postsynaptic PotentialsFemaleGlutamic AcidMaleMiceModels, NeurologicalNeocortexOrganometallic CompoundsPyramidal CellsShal Potassium ChannelsSpider Venoms4-AminopyridineGlutamic AcidOrganometallic Compoundsphrixotoxin-2RuBi-glutamateShal Potassium ChannelsSpider Venoms4-AminopyridineI(A)MiceNeocortexPhrixotoxin-2RuBi-glutamate

Identifiers

PMID30009837
PMCPMC6137074
OpenAlexW2879560096

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.